Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
Catheter Precision, Inc., a Delaware corporation, filed this Current Report on Form 8-K on November 13, 2024. The filing serves to announce the Company's financial results for the quarter ended September 30, 2024. The report was signed by Margrit Thomassen, Interim Chief Financial Officer, on November 14, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Item 2.02 states that the full financial results are contained in a press release attached as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
No material changes versus the prior comparable period are detailed in the provided text. The document acts as a notification of the results rather than a detailed financial statement.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items within the main body text. It explicitly notes that the information furnished in Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q3 2024 financial figures.
- Verify the status of the Interim Chief Financial Officer and any leadership transitions.
- Confirm whether the press release contains forward-looking statements or updated guidance.
- Check for any subsequent filings that may incorporate the press release data by reference.